About Index Trending news
Lists
Pricing
Orphazyme

Orphazyme

Orphazyme

Orphazyme develops innovative new therapies for the treatment of a family ofserious genetic disorders called lysosomal storage diseases.

Elsewhere

Contributors to this profile

Alexa global traffic share

Latest funding Show all
Venture capital
Aescap Venture, ALS Investment Fund, LSP Health Economics Fund
Venture capital (Series B)
$24,000,000
Employees

Unknown size

Locations
HQ
Headquarters

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Orphazyme makes some noise.